House Oversight Committee’s Hearing on ‘Hemp in the Modern World: The Yearslong Wait for FDA Action’

The House Oversight Committee Health Care and Financial Services Subcommittee holds a hearing on “Hemp in the Modern World: The Yearslong Wait for FDA Action” at 2:00 p.m. ET on July 27.

Witnesses and testimonies:

Jonathan S. Miller, general counsel of U.S. Hemp Roundtable
Rayetta G. Henderson, Ph.D., senior managing scientist of ToxStrategies, LLC
Richard A. Badaracco, president-elect, Kentucky Narcotic Officers Association, (Retired) assistant special agent in charge, U.S. Drug Enforcement Administration
Gillian L. Schauer, Ph.D., MPH (Minority Witness), executive director, Cannabis Regulators Association (CANNRA)